{"page":"\n\n
\n
\n
\n
\n
\n\nVideo\n
\n

\nInvesting in China's Biotech: Opportunities and Risks\n

\n
\n
\nGet Free Access for 10 Days!\n
\n
\n
\n
\n
\n
×
\n\n\n
\n\nPublisher:\n\nThe Wall Street Journal\n\n\n
\n
\nChina has poured billions of dollars into cultivating a homegrown biotechnology industry, but how soon can it challenge U.S. rivals? Lilly Asia Ventures' Judith Li and Qiming Venture Partners' Nisa Leung discuss with WSJ Health and...\nChina has poured billions of dollars into cultivating a homegrown biotechnology industry, but how soon can it challenge U.S. rivals? Lilly Asia Ventures' Judith Li and Qiming Venture Partners' Nisa Leung discuss with WSJ Health and Science Bureau Chief Stefanie Ilgenfritz at the WSJ D.Live conference in Hong Kong.\n
\n
\n\n
\n
\n
\n
\n

Resource Details

\n
\n
\n
\n
Curator Rating
\n
\n
\n
\n
\n
\n
Educator Rating
Not yet Rated
\n
\n
\n
\n
\n
Media Length
\n
19:34
\n
\n
\n
\n
\n
Grade
Higher Ed
\n
\n
\n
\n
\n
Subjects
Social Studies & History
3 more...
\n
\n
\n
\n
\n
Media Type
Instructional Videos
\n
\n
\n
\n
\n
Source:
\n
\nThe Wall Street Journal\n\n
\n
\n
\n
\n
\n
Date
\n
2018
\n
\n
\n
\n
\n\n
Language
English
\n
\n
\n
\n
\n
Audiences
For Teacher Use
2 more...
\n
\n
\n
\n
\n
Usage Permissions
Fine Print: Educational Use
\n
\n
\n
\n
\n
\n

Additional Materials

\n
\n\nSign in or Join Now
\" data-title=\"Get Full Access\" data-container=\"body\" rel=\"popover\" tabindex=\"0\" href=\"/subscription/new\">Video Transcript\n
\n
\n\nSign in or Join Now
\" data-title=\"Get Full Access\" data-container=\"body\" rel=\"popover\" tabindex=\"0\" href=\"/subscription/new\">Video Preview\n
\n
\n
\n

Concepts

\n
\n
money, volume, drugs, companies, risks, governments
\n
\n\n\n
\n
\n
\n
\n

Additional Tags

\n
\n
wsj dlive 2018 asia, funds, innovative, opportunities, developing countries, wsj, tech, provide, dilive asia, areas, leung, life sciences, development, lilly asia ventures, raise money, products approved, medical, wsj dlive asia, stages, venture, biotech companies, approved, difficult, biotechnology industry, dlive 2018 asia, government grants, conference, chinese companies, medical reimbursement, judith li, nisa leung, tech companies, chinese biotech, biologic drugs, biotech, patient, coming, qiming venture partners, chinese government, early stage
\n
\n\n\n
\n
\n
\n
\n

Classroom Considerations

\n
Video is ad-free
\n
\n
\n

Educator Ratings

\n
\n
\n
\n
\n
\n\nShow resource details\n
\n
\n\" data-title=\"Get Full Access\" data-container=\"body\" rel=\"popover\" tabindex=\"0\" aria-label=\"Play video: Investing in China's Biotech: Opportunities and Risks\" href=\"/subscription/new\">\"Investing\n\n
\n
\n
\n\n\n\n"}